Clinical Trial Details
EORTC-55012
Back to Clinical Trials Database
A phase III study of Cisplatin plus Topotecan followed by Paclitaxel plus Carboplatin versus Paclitaxel plus Carboplatin as first line chemotherapy in women with newly diagnosed advanced epithelial ovarian cancer.
| Trial Status | All trial activities ended |
|---|---|
| Dates |
Date of activation: 08-May-2002 Date Step1 close: 30-Jun-2005 |
| Data management at EORTC | No |
| Design |
Phase 3 Randomized open label |
| Targeted Sample size | EORTC Groups: 800 |
| Treatment | |
| Study Staff | |
| Type of cancer | |
| Participating groups | |
| Protocol summary | http://clinicaltrials.gov/study/NCT00028743 |
| NCT number | NCT00028743 |
